Viking Therapeutics Advances Multiple Therapies Amid Strong Clinical Progress and Financial Stability
Obesity Drug VK2735 to Enter Phase 3, NASH Therapy VK2809 Shows Promising Results, and Novel Treatments in Development Viking Therapeutics ...
Tag: biotech
Eli Lilly’s GLP-1 Drugs Outshine Novo Nordisk’s in Weight Loss: A New Study Confirms
Independent research underscores the superior weight loss efficacy of Eli Lilly's Mounjaro over Novo Nordisk's Ozempic, stirring debate and market ...
